Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
We know from a number of older, epidemiologic studies that there seems to be an inverse association between diabetes status and prostate cancer risk. In other words, people with diabetes seem to be less likely to be diagnosed with prostate cancer.
Filed under: Diagnosis, Prevention, Risk | Tagged: allele, diabetes, genetics, genome, risk | Leave a Comment »
Under the “And this helps me how?” column we can now add the topic of a possible genetic link between endometrial cancer and prostate cancer (maybe).
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: cancer, endometrial, genome, SNP, womb | Leave a Comment »
There has been little doubt over the years that prostate cancer was a genetically complex disease. No one has ever seriously thought that prostate cancer was the result of a single change in the DNA of the individual patient. Now we finally have some proof!
Filed under: Diagnosis, Management, Prevention, Risk | Tagged: Diagnosis, genome, prognosis, risk | 3 Comments »
A large study of genetic markers in Japanese prostate cancer patients has clearly shown that some of the markers of prostate cancer in Caucasians do not appear in Japanese patients whereas new markers appear to be common among Japanese.
Filed under: Diagnosis, Risk | Tagged: association, genetics, genome, SNP | Leave a Comment »
Today’s news reports deal with such items as: Genomic testing for prostate cancer and the value of specific SNPs What do pre-treatment MRI/MRSI tests and molecular profiling add to prognostic significance? Quality of life following salvage brachytherapy
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: brachytherapy, Diagnosis, genome, MRI, MRSI, prognosis, quality of life, salvage, SNPs | 2 Comments »
In today’s news report we touch on papers that address: Genome studies and identification of real genomic risk for prostate cancer More on the potential of 5-ARIs in prevention of prostate cancer Whether we really need more studies on selenium as a potential prostate cancer prevention agent The evolving potential of targeted focal therapy
Filed under: Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: 5α-reductase inhibitor, focal therapy, genome, marker, Prevention, risk, selenium, SNP, targeted | Leave a Comment »
The New York Times has started a series of science articles for its readers on “the frontiers of biology,” which may be helpful and entertaining for at least some readers of this blog. The first article, by Nick Wade, addresses what a genome is and how it actually works. However, there seems to be no [...]
Filed under: Uncategorized | Tagged: genome | Comments Off
Search for new and
ongoing trials on the
CTAG PCa web site